This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Is Canada's medicines review board really holding down costs?. Pharmacoecon. Outcomes News 394, 3–4 (2003). https://doi.org/10.1007/BF03275698
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275698